Dr Zhou Lihan is bolstering the future of preventive healthcare
On the eve of Mirxes’s listing application with The Stock Exchange of Hong Kong Limited, CBD sat down with the biotech’s far-sighted CEO and co-founder Dr Zhou Lihan to find out how cognitive diversity lends to his firm’s advancements in making the early detection of diseases accessible on a global scale.
Growth and profitability must be met with good governance says Tan Yinglan
For any company, much less a startup, the ability to see the bigger picture can only come from having a board and management that are diverse in not just gender and skills, but also age and experience. The founder and managing partner of Insignia Ventures Partners chats with CBD.